Join TPS Members to review the newly released CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Understand what this means for you in your practice. What changes do you need to make immediately? How does this impact the way you are treating pain patients? Attend to find out. 

Presented by :
C.M. Schade, MD, PhD
Graves T. Owen, MD
Allen Dennis, MD

The event is discounted to $40 for TPS Members.
Please login to your TPS Member account to register.

Non-TPS Members $100 registration
Register Here
Note, this event will not be recorded. Must be present to receive CME, logged in no later than 15 minutes after the start, and stay through the entirety. 

CME

The Texas Pain Society is accredited by the Texas Medical Association to provide continuing medical education for physicians.

This course has been designated by Texas Pain Society for 1 credit of education in medical ethics and/or professional responsibility.

OBJECTIVE

  • Identify the 12 new recommendations in the newly revised guidelines
  • Understand what the new guidelines mean for your practice
  • Understand that the 2022 new guidelines fall short of what people in pain need.
View the new guidelines

Target Audience

Texas physicians, advanced practice nurses, nurse practitioners and physician assistants.


Disclosures to the Learner:

1. Notice of requirements for successful completion of continuing education activity:

  • Register for the course
  • Attend the live presentation in its entirety- Must be logged on with name visible no later than 15 minutes after the start of the program and must remain in the course to its entirety. 
  • Complete the Evaluation

2. The Texas Pain Society's live course has received no commercial support. 

3. Disclosure of financial relationships:

The speakers and/or committee members have no financial relationships to disclose. 

4. Non-endorsement Statement:

Accredited status does not imply endorsement of any commercial products or services by the Texas Pain Society.

5. Off-Label Use:

There is no discussion of off-label use in this presentation.